Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, Not Recruiting

A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients

NCT06540391

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Centre Georges Francois Leclerc Dijon, France
  • CHU de Lille - Hopital Claude Huriez Lille, France
  • Centre Leon Berard Lyon, France
  • AP-HM - Hopital de la Timone Marseille, France
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

NCT04674683

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Innovative Clinical Research Institute (ICRI) Pasadena, California, United States
  • Emad Ibrahim, MD, INC Redlands, California, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

NCT05933577

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Highlands Oncology Group ( Site 1943) Springdale, Arkansas, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1918) Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay ( Site 1929) San Francisco, California, United States
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 1933) New Haven, Connecticut, United States
View all 165 locations
View Trial Details
Active, Not Recruiting

A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas

NCT04808245

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Department of Neurology and Polyclinic, Universitiy Clinic Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • University Medical Center Mannheim, Department of Neurology Mannheim, Baden-Wurttemberg, Germany
  • University Clinic Tuebingen, Neurological Clinic, Department of Neurology Tübingen, Baden-Wurttemberg, Germany
  • Dr. Senckenberg Institute for Neurooncology, University Hospital Frankfurt Frankfurt am Main, Hesse, Germany
View Trial Details
Active, Not Recruiting

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

NCT05634707

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, Recurrent, +18 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • NYU Langone Health New York, United States
  • The Preston Robert Tisch Brain Tumor Center at Duke University Durham, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

NCT05309421

Conditions
Melanoma, Melanoma Stage IV, Neoplasms, +11 more
Locations
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
  • Divisione di Oncologia Medica del Melanoma Milan, Italy
  • Instituto Nazionale Tumori IRCCS Fondazione Naples, Italy
View Trial Details

Related conditions